BerGenBio To Present Preclinical Covid-19 Data At The Conference On Retroviruses And Opportunistic Infections (CROI 2021) ...Middle East

BERGEN, Norway, Feb. 17, 2021 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that its abstract has been accepted for an oral virtual presentation...

Hence then, the article about bergenbio to present preclinical covid 19 data at the conference on retroviruses and opportunistic infections croi 2021 was published today ( Wednesday 17/02/2021 - 10:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BerGenBio To Present Preclinical Covid-19 Data At The Conference On Retroviruses And Opportunistic Infections (CROI 2021) )

Also on site :

• This CEO became 3x more productive with AI. Then she read what her daughter wrote about it at Dartmouth
• Ukrainian colonel behind attempted terror attack in Crimea eliminated – media
• Costco's New Cookie Is Perfect for America's 250th Birthday Celebrations